Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Observer-blind Study to Rank Different Formulations of GSK Biologicals' Investigational RSV Vaccine (GSK3003891A) Administered to Healthy Women
Brief Summary: The purpose of this study is to rank different RSV vaccine dosages of antigen (or formulations) based on safety/reactogenicity and immune response data. The formulations eliciting strong immune responses while maintaining an acceptable safety profile will be considered for further evaluation, including in studies vaccinating pregnant women.


Options:
A: Arm Label: EDP-938 Arm A; Type: EXPERIMENTAL; Interventions: Drug: EDP-938 Dose 1 | Arm Label: EDP-938 Arm B; Type: EXPERIMENTAL; Interventions: Drug: EDP-938 Dose 2 | Arm Label: Placebo Arm C; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: EDP-938 Arm D; Type: EXPERIMENTAL; Interventions: Drug: EDP-938 Dose 3 | Arm Label: EDP-938 Arm E; Type: EXPERIMENTAL; Interventions: Drug: EDP-938 Dose 4 | Arm Label: Placebo Arm F; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: EDP-938 Dose 1; Assigned to Arm(s): EDP-938 Arm A | Intervention Type: DRUG; Name: EDP-938 Dose 2; Assigned to Arm(s): EDP-938 Arm B | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo Arm C | Intervention Type: DRUG; Name: EDP-938 Dose 3; Assigned to Arm(s): EDP-938 Arm D | Intervention Type: DRUG; Name: EDP-938 Dose 4; Assigned to Arm(s): EDP-938 Arm E | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo Arm F
B: Arm Label: GSK3003891A vaccine formulation 1 Group; Type: EXPERIMENTAL; Interventions: Biological: RSV Vaccine (GSK3003891A) formulation 1 | Arm Label: GSK3003891A vaccine formulation 2 Group; Type: EXPERIMENTAL; Interventions: Biological: RSV Vaccine (GSK3003891A) formulation 2 | Arm Label: GSK3003891A vaccine formulation 3 Group; Type: EXPERIMENTAL; Interventions: Biological: RSV Vaccine (GSK3003891A) formulation 3 | Arm Label: Control Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (Formulation buffer S9b) | Intervention Type: BIOLOGICAL; Name: RSV Vaccine (GSK3003891A) formulation 1; Assigned to Arm(s): GSK3003891A vaccine formulation 1 Group | Intervention Type: BIOLOGICAL; Name: RSV Vaccine (GSK3003891A) formulation 2; Assigned to Arm(s): GSK3003891A vaccine formulation 2 Group | Intervention Type: BIOLOGICAL; Name: RSV Vaccine (GSK3003891A) formulation 3; Assigned to Arm(s): GSK3003891A vaccine formulation 3 Group | Intervention Type: DRUG; Name: Placebo (Formulation buffer S9b); Assigned to Arm(s): Control Group
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Soap | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Soap; Assigned to Arm(s): 1
D: Arm Label: RSV D46/NS2/N/ΔM2-2-HindIII Vaccine; Type: EXPERIMENTAL; Interventions: Biological: D46/NS2/N/ΔM2-2-HindIII | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: D46/NS2/N/ΔM2-2-HindIII; Assigned to Arm(s): RSV D46/NS2/N/ΔM2-2-HindIII Vaccine | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B